Advanced Search

Technical Analysis for FMTX - Forma Therapeutics Holdings, Inc.

Grade Last Price % Change Price Change
F 38.97 7.12% 2.59
FMTX closed up 7.12 percent on Friday, January 22, 2021, on approximately normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical FMTX trend table...
Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Fell Below 20 DMA Bearish 7.12%
Down 3 Days in a Row Weakness 7.12%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.19%
20 DMA Support Bullish 6.19%
Outside Day Range Expansion 6.19%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.95%
Crossed Above 20 DMA Bullish 3.92%
Older End-of-Day Signals for FMTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 15 hours ago
Up 1 ATR about 15 hours ago
Up 5% about 16 hours ago
Rose Above Previous Day's High about 16 hours ago
Outside Day about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancers Regulus Therapeutics Pharmaceutical Companies Trubion

Is FMTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 20 Dosing underway in Forma Therapeutics' study of FT-7051 in prostate cancer
Jan 20 Forma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating FT-7051 for the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
Jan 11 Forma Therapeutics Reviews 2020 Highlights and Outlines Key 2021 Milestones
Jan 7 Forma Therapeutics Elects Renowned Doctor and Health Disparities Expert Selwyn M. Vickers, M.D., to Board of Directors
Dec 19 How Much Of Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Do Institutions Own?
Dec 16 Forma Therapeutics closes public offering priced at $45.25
Dec 15 Forma Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Dec 11 Forma Therapeutics prices equity offering at $45.25
Dec 11 Forma Therapeutics Announces Pricing of Public Offering
Dec 10 Is FMTX A Good Stock To Buy Now?
See more FMTX news...

Indicators

Indicator Value
52 Week High 56.33
52 Week Low 31.45
Average Volume 424,378
200-Day Moving Average 0.00
50-Day Moving Average 39.77
20-Day Moving Average 36.47
10-Day Moving Average 36.80
Average True Range 2.58
ADX 15.46
+DI 20.94
-DI 18.69
Chandelier Exit (Long, 3 ATRs ) 32.35
Chandelier Exit (Short, 3 ATRs ) 40.44
Upper Bollinger Band 39.64
Lower Bollinger Band 33.31
Percent B (%b) 0.89
BandWidth 17.38
MACD Line -0.84
MACD Signal Line -1.35
MACD Histogram 0.5022
Fundamentals Value
Market Cap 1.6 Billion
Num Shares 41.2 Million
EPS -1.40
Price-to-Earnings (P/E) Ratio -27.93
Price-to-Sales 255.15
Price-to-Book 4.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 45.23
Resistance 3 (R3) 44.62 41.94 44.18
Resistance 2 (R2) 41.94 40.34 42.24 43.83
Resistance 1 (R1) 40.45 39.36 41.20 41.06 43.49
Pivot Point 37.77 37.77 38.14 38.07 37.77
Support 1 (S1) 36.28 36.17 37.03 36.89 34.45
Support 2 (S2) 33.60 35.19 33.90 34.11
Support 3 (S3) 32.11 33.60 33.76
Support 4 (S4) 32.72